Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
To date, the company has raised over $34 million from investors and operates a 15-person team at facilities at Johns Hopkins Medical Campus.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...
Oral and Facial Surgery Associates, LLC is pleased to announce that Dr. Christopher R. Cason, DMD, FACS, is joining the practice as an oral and maxillofacial surgeon. Dr. Cason brings extensive ...
Data support AGAMREE®’s potential use as a treatment across a broad range of chronic inflammatory rare diseases ...
FDA expands Casgevy CRISPR gene therapy to children aged 2+ with sickle cell disease and beta thalassemia, enabling earlier ...
A total of 235,244 people claim PIP for health conditions across Greater Manchester ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results